What Researchers Did
This systematic review and meta-analysis evaluated the efficacy and safety of hyperbaric oxygen therapy (HBOT) for radiation-induced hemorrhagic cystitis (RHC).
What They Found
Out of 556 patients across fourteen studies, 500 patients (89.9%) experienced symptom improvement. The meta-analysis revealed that 55% of patients treated with HBOT achieved complete remission of hematuria (95% CI 51-59%).
What This Means for Canadian Patients
Canadian patients suffering from radiation-induced hemorrhagic cystitis may find hyperbaric oxygen therapy to be an effective treatment option for improving symptoms and achieving remission of hematuria. This therapy could offer a non-invasive approach to manage this challenging condition.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The study did not explicitly detail limitations regarding the quality or heterogeneity of the primary studies included in the meta-analysis.